1 |
Le J, Ngu B, Bradley JS, Murray W, Nguyen A, Nguyen L, Romanowski GL, Vo T, Capparelli EV. Vancomycin monitoring in children using bayesian estimation. Ther Drug Monit 2014;36:510-8. [PMID: 24452067 DOI: 10.1097/FTD.0000000000000039] [Cited by in Crossref: 29] [Cited by in F6Publishing: 9] [Article Influence: 4.1] [Reference Citation Analysis]
|
2 |
Monteiro JF, Hahn SR, Gonçalves J, Fresco P. Vancomycin therapeutic drug monitoring and population pharmacokinetic models in special patient subpopulations. Pharmacol Res Perspect 2018;6:e00420. [PMID: 30156005 DOI: 10.1002/prp2.420] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
|
3 |
Balch AH, Constance JE, Thorell EA, Stockmann C, Korgenski EK, Campbell SC, Spigarelli MG, Sherwin CM. Pediatric vancomycin dosing: Trends over time and the impact of therapeutic drug monitoring. J Clin Pharmacol 2015;55:212-20. [PMID: 25264036 DOI: 10.1002/jcph.402] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
|
4 |
Hennessy K, Capparelli EV, Romanowski G, Alejandro L, Murray W, Benador N. Intraperitoneal vancomycin for peritoneal dialysis-associated peritonitis in children: Evaluation of loading dose guidelines. Perit Dial Int 2021;41:202-8. [DOI: 10.1177/0896860820950924] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|